Where is Adagene headquartered?

Adagene is located in Suzhou, jiangsu province.

Who invested in Adagene?

Adagene has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Adagene?

Adagene closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

adagene.com

Adagene

Adagene is a pharmaceutical company that researches and develops antibody therapeutics for the treatment of cancer.

Business Model:

Revenue: $10.2M

Employees: 51-200

Geographic Data

Address: No. 218, Xinghu Street

City: Suzhou

State: jiangsu province

Zip: 215123

Country: CN

Financial Info

Stage:

post ipo equity

Raised Last:

$0

Raised Total:

$155M

Social

Facebook

Twitter

Crunchbase

Metrics

2,640,910Website Global Rank

6,667Website Monthly Traffic

Twitter Followers

Description

Adagene is a pharmaceutical company that researches and develops antibody therapeutics for the treatment of cancer.

Contact Phone:

Contact Email:

IPO Details

Adagene went public on 2/9/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/9/2021

IPO Valuation:
$1B

Ticker Symbol:
ADAG

IPO Price:
$19/share

Amount Raised:
$140M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2020	Series D		$0	F-Prime Capital Eight Roads Ventures Wuxi Venture Capital Group General Atlantic Sequoia Capital China General Atlantic F-Prime Capital Eight Roads Ventures Wuxi Venture Capital Group General Atlantic Sequoia Capital China General Atlantic
3/2018	Series C		$0	AVIC Trust Gopher Asset Management King Star Capital New World TMT Ltd Sequoia Capital China AVIC Trust Gopher Asset Management King Star Capital New World TMT Ltd Sequoia Capital China
2/2021	IPO		$139.7M
12/2014	Series A	2	$8M	WuXi Healthcare Ventures F-Prime Capital
1/2011	Seed Round	1	-	Eight Roads Ventures Eight Roads Ventures
2/2021	Post-IPO Equity		-
1/2016	Series B		$0	GP Healthcare Capital Eight Roads Ventures F-Prime Capital New World TMT Ltd WuXi Healthcare Ventures GP Healthcare Capital Eight Roads Ventures F-Prime Capital New World TMT Ltd WuXi Healthcare Ventures
1/2020	Series D	5	$69M	General Atlantic F-Prime Capital Eight Roads Ventures Wuxi Venture Capital Group General Atlantic Sequoia Capital China General Atlantic
3/2018	Series C	5	$50M	Sequoia China New World TMT AVIC Trust Gopher Asset Management Gopher Asset Management New World TMT Ltd AVIC Trust Sequoia Capital China King Star Capital Sequoia Capital China
1/2016	Series B	5	$28M	New World TMT Ltd Eight Roads Ventures China F-Prime Capital WuXi Corporate Venture Fund GP Healthcare Capital
2/2021	Post-IPO Equity		-
1/2011	Seed Round	1	-

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details